Literature DB >> 19386596

The superagonistic activity of bovine thyroid-stimulating hormone (TSH) and the human TR1401 TSH analog is determined by specific amino acids in the hinge region of the human TSH receptor.

Sandra Mueller1, Gunnar Kleinau, Mariusz W Szkudlinski, Holger Jaeschke, Gerd Krause, Ralf Paschke.   

Abstract

Bovine TSH (bTSH) has a higher affinity to the human TSHR (hTSHR) and a higher signaling activity than human TSH (hTSH). The molecular reasons for these phenomena are unknown. Distinct negatively charged residues (Glu297, Glu303, and Asp382) in the hinge region of the hTSHR are known to be important for bTSH binding and signaling. To investigate the potential relevance of these positions for differences between bTSH and hTSH in the interaction to the hTSHR, we determined bTSH- and hTSH-mediated cAMP production of several substitutions at these three hinge residues. To examine specific variations of hTSH, we also investigated the superagonistic hTSH analog TR1401 (TR1401), whose sequence differs from hTSH by four additional positively charged amino acids that are also present in bTSH. To characterize possible interactions between the acidic hTSHR positions Glu297, Glu303, or Asp382 and the additional basic residues of TR1401, we investigated TR1401 binding and signaling properties. Our data reveal increased cAMP signaling of the hTSHR using TR1401 and bTSH compared with hTSH. Whereas Asp382 seems to be important for bTSH- and TR1401-mediated but not for hTSH-mediated signaling, the substitution E297K exhibits a decreased signaling for all three TSH variants. Interestingly, bTSH and TR1401 showed only a slightly different binding pattern. These observations imply that specific residues of the hinge region are mediators of the superagonistic activity of bTSH and TR1401 in contrast to hTSH. Moreover, the simultaneous localization of binding components in the glycoprotein hormone molecule and the receptor hinge region permits important reevaluation of interacting hormone receptor domains.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19386596      PMCID: PMC2713536          DOI: 10.1074/jbc.M109.005710

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  The ectodomain of the luteinizing hormone receptor interacts with exoloop 2 to constrain the transmembrane region: studies using chimeric human and fly receptors.

Authors:  Shinya Nishi; Koji Nakabayashi; Brian Kobilka; Aaron J W Hsueh
Journal:  J Biol Chem       Date:  2001-11-26       Impact factor: 5.157

2.  The role of the hinge region of the luteinizing hormone receptor in hormone interaction and signal generation.

Authors:  H Zeng; T Phang; Y S Song; I Ji; T H Ji
Journal:  J Biol Chem       Date:  2000-08-29       Impact factor: 5.157

3.  Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors.

Authors:  S Costagliola; V Panneels; M Bonomi; J Koch; M C Many; G Smits; G Vassart
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

Review 4.  Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships.

Authors:  Mariusz W Szkudlinski; Valerie Fremont; Catherine Ronin; Bruce D Weintraub
Journal:  Physiol Rev       Date:  2002-04       Impact factor: 37.312

5.  A novel germline mutation in the TSH receptor gene causes non-autoimmune autosomal dominant hyperthyroidism.

Authors:  L Alberti; M C Proverbio; S Costagliola; G Weber; P Beck-Peccoz; G Chiumello; L Persani
Journal:  Eur J Endocrinol       Date:  2001-09       Impact factor: 6.664

6.  Activation of the luteinizing hormone receptor following substitution of Ser-277 with selective hydrophobic residues in the ectodomain hinge region.

Authors:  K Nakabayashi; M Kudo; B Kobilka; A J Hsueh
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

Review 7.  Thyrotropin receptor mutations as a tool to understand thyrotropin receptor action.

Authors:  P Wonerow; S Neumann; T Gudermann; R Paschke
Journal:  J Mol Med (Berl)       Date:  2001-09-12       Impact factor: 4.599

8.  Characterization of the thyrotropin binding pocket.

Authors:  Jennifer Jeffreys; Hilde Depraetere; Jane Sanders; Yasuo Oda; Michele Evans; Angela Kiddie; Tonya Richards; Jadwiga Furmaniak; Bernard Rees Smith
Journal:  Thyroid       Date:  2002-12       Impact factor: 6.568

9.  Activation of the luteinizing hormone receptor in the extracellular domain.

Authors:  Koji Nakabayashi; Masataka Kudo; Aaron J W Hsueh; Takeshi Maruo
Journal:  Mol Cell Endocrinol       Date:  2003-04-28       Impact factor: 4.102

10.  The thyrotropin receptor hinge region is not simply a scaffold for the leucine-rich domain but contributes to ligand binding and signal transduction.

Authors:  Yumiko Mizutori; Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Mol Endocrinol       Date:  2008-01-24
View more
  22 in total

1.  Allosteric modulators hit the TSH receptor.

Authors:  Terry F Davies; M Rejwan Ali; Rauf Latif
Journal:  Endocrinology       Date:  2014-01       Impact factor: 4.736

2.  Thyrotropin Causes Dose-dependent Biphasic Regulation of cAMP Production Mediated by Gs and Gi/o Proteins.

Authors:  Susanne Neumann; Sarah S Malik; Bernice Marcus-Samuels; Elena Eliseeva; Daesong Jang; Joanna Klubo-Gwiezdzinska; Christine C Krieger; Marvin C Gershengorn
Journal:  Mol Pharmacol       Date:  2019-11-08       Impact factor: 4.436

3.  A stimulatory thyrotropin receptor antibody enhances hyaluronic acid synthesis in graves' orbital fibroblasts: inhibition by an IGF-I receptor blocking antibody.

Authors:  Seema Kumar; Seethalakshmi Iyer; Hilary Bauer; Michael Coenen; Rebecca S Bahn
Journal:  J Clin Endocrinol Metab       Date:  2012-03-07       Impact factor: 5.958

4.  Research resource: novel structural insights bridge gaps in glycoprotein hormone receptor analyses.

Authors:  Annika Kreuchwig; Gunnar Kleinau; Gerd Krause
Journal:  Mol Endocrinol       Date:  2013-06-24

Review 5.  Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor.

Authors:  Seethalakshmi Iyer; Rebecca Bahn
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-06       Impact factor: 4.690

6.  (99m)Tc-labeled-rhTSH analogue (TR1401) for imaging poorly differentiated metastatic thyroid cancer.

Authors:  Filippo Galli; Isabella Manni; Giulia Piaggio; Lajos Balogh; Bruce D Weintraub; Mariusz W Szkudlinski; Valerie Fremont; Rudi A J O Dierckx; Alberto Signore
Journal:  Thyroid       Date:  2014-06-20       Impact factor: 6.568

Review 7.  Targeting the thyroid-stimulating hormone receptor with small molecule ligands and antibodies.

Authors:  Terry F Davies; Rauf Latif
Journal:  Expert Opin Ther Targets       Date:  2015-03-13       Impact factor: 6.902

8.  The thyrotropin receptor hinge region as a surrogate ligand: identification of loci contributing to the coupling of thyrotropin binding and receptor activation.

Authors:  Chun-Rong Chen; Larry M Salazar; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2012-10       Impact factor: 4.736

9.  Rearrangement of the Extracellular Domain/Extracellular Loop 1 Interface Is Critical for Thyrotropin Receptor Activation.

Authors:  Joerg Schaarschmidt; Marcus B M Nagel; Sandra Huth; Holger Jaeschke; Rocco Moretti; Vera Hintze; Martin von Bergen; Stefan Kalkhof; Jens Meiler; Ralf Paschke
Journal:  J Biol Chem       Date:  2016-04-26       Impact factor: 5.157

Review 10.  Novel insights on thyroid-stimulating hormone receptor signal transduction.

Authors:  Gunnar Kleinau; Susanne Neumann; Annette Grüters; Heiko Krude; Heike Biebermann
Journal:  Endocr Rev       Date:  2013-05-03       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.